Laroche Richard F Jr - May 9, 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Richard F. LaRoche, Jr.
Stock symbol
NHC
Transactions as of
May 9, 2024
Transactions value $
$0
Form type
4
Date filed
5/13/2024, 05:34 PM
Previous filing
May 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock (held in my name or my wife's name) 201K May 9, 2024 Direct
holding NHC Common Stock (ROTH IRA) 115 May 9, 2024 Direct
holding NHC Common Stock - Family LP (BFLP) 30K May 9, 2024 GP
holding NHC Common Stock - Fam. Partnership (LR Ent.) 28K May 9, 2024 Direct
holding NHC Common Stock - Fam. Partnership (LFLP) 96K May 9, 2024 GP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2024 Grant] Award $0 +7.5K $0.00 7.5K May 9, 2024 Common Stock 7.5K $96.03 Direct F1
holding NHC Option to Purchase Common Stock [2020 Grant] 5K May 9, 2024 Common Stock 5K $64.64 Direct
holding NHC Option to Purchase Common Stock [2021 Grant] 7.5K May 9, 2024 Common Stock 7.5K $71.64 Direct F2
holding NHC Option to Purchase Common Stock [2022 Grant] 7.5K May 9, 2024 Common Stock 7.5K $69.19 Direct F2
holding NHC Option to Purchase Common Stock [2023 Grant] 7.5K May 9, 2024 Common Stock 7.5K $55.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 The expiration date of these options was inadvertently reported incorrectly on prior Form 4s and is corrected here.